BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 31293091)

  • 21. Hürthle cell neoplasms diagnosed by fine needle aspiration are not associated with an increased risk of malignancy.
    McKee S; Wu H; Wang X; Cramer H; Lin J; Chen S
    Acta Cytol; 2014; 58(3):235-8. PubMed ID: 24819535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of specific patterns on the sensitivity for follicular and Hurthle cell carcinoma in thyroid fine-needle aspiration.
    Renshaw AA; Gould EW
    Cancer Cytopathol; 2016 Oct; 124(10):729-736. PubMed ID: 27322887
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementing noninvasive follicular thyroid neoplasm with papillary-like nuclear features may potentially impact the risk of malignancy for thyroid nodules categorized as AUS/FLUS and FN/SFN.
    Li W; Sciallis A; Lew M; Pang J; Jing X
    Diagn Cytopathol; 2018 Feb; 46(2):148-153. PubMed ID: 29193839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic performance of molecular testing in indeterminate (Bethesda III and IV) thyroid nodules with Hürthle cell cytology.
    Raghunathan R; Longstaff XR; Hughes EG; Li SJ; Sant VR; Tseng CH; Rao J; Wu JX; Yeh MW; Livhits MJ
    Surgery; 2024 Jan; 175(1):221-227. PubMed ID: 37926582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative diagnostic categories of fine needle aspiration cytology for histologically proven thyroid follicular adenoma and carcinoma, and Hurthle cell adenoma and carcinoma: Analysis of cause of under- or misdiagnoses.
    Na HY; Moon JH; Choi JY; Yu HW; Jeong WJ; Kim YK; Choe JY; Park SY
    PLoS One; 2020; 15(11):e0241597. PubMed ID: 33147258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance of a Multigene Genomic Classifier in Thyroid Nodules With Indeterminate Cytology: A Prospective Blinded Multicenter Study.
    Steward DL; Carty SE; Sippel RS; Yang SP; Sosa JA; Sipos JA; Figge JJ; Mandel S; Haugen BR; Burman KD; Baloch ZW; Lloyd RV; Seethala RR; Gooding WE; Chiosea SI; Gomes-Lima C; Ferris RL; Folek JM; Khawaja RA; Kundra P; Loh KS; Marshall CB; Mayson S; McCoy KL; Nga ME; Ngiam KY; Nikiforova MN; Poehls JL; Ringel MD; Yang H; Yip L; Nikiforov YE
    JAMA Oncol; 2019 Feb; 5(2):204-212. PubMed ID: 30419129
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of a cytomorphological subclassification of follicular patterned thyroid lesions: a study of 927 consecutive cases with histological correlation.
    Deandrea M; Ragazzoni F; Motta M; Torchio B; Mormile A; Garino F; Magliona G; Gamarra E; Ramunni MJ; Garberoglio R; Limone PP
    Thyroid; 2010 Oct; 20(10):1077-83. PubMed ID: 20883171
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid Ultrasound-Guided Fine-Needle Aspiration Cytology Results: Observed Increase in Indeterminate Rate over the Past Decade.
    Manning AM; Yang H; Falciglia M; Mark JR; Steward DL
    Otolaryngol Head Neck Surg; 2017 Apr; 156(4):611-615. PubMed ID: 28118554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.
    Nikiforova MN; Mercurio S; Wald AI; Barbi de Moura M; Callenberg K; Santana-Santos L; Gooding WE; Yip L; Ferris RL; Nikiforov YE
    Cancer; 2018 Apr; 124(8):1682-1690. PubMed ID: 29345728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of ThyroSeq V3 testing in the management of patients with indeterminate thyroid nodules on fine needle aspiration.
    Selvaggi SM
    Diagn Cytopathol; 2021 Jul; 49(7):838-841. PubMed ID: 33864719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Copy number variations identified in thyroid FNA specimens are associated with Hürthle cell cytomorphology.
    Abi-Raad R; Prasad ML; Adeniran AJ; Cai G
    Cancer Cytopathol; 2022 Jun; 130(6):415-422. PubMed ID: 35332982
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.
    Strickland KC; Howitt BE; Barletta JA; Cibas ES; Krane JF
    Cancer Cytopathol; 2018 Feb; 126(2):86-93. PubMed ID: 28914983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular-derived estimation of risk of malignancy for indeterminate thyroid cytology diagnoses.
    Ohori NP; Landau MS; Manroa P; Schoedel KE; Seethala RR
    J Am Soc Cytopathol; 2020; 9(4):213-220. PubMed ID: 32336670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probability of malignancy as determined by ThyroSeq v3 genomic classifier varies according to the subtype of atypia.
    Gajzer DC; Tjendra Y; Kerr DA; Algashaamy K; Zuo Y; Menendez SG; Jorda M; Garcia-Buitrago M; Gomez-Fernandez C; Velez Torres JM
    Cancer Cytopathol; 2022 Nov; 130(11):881-890. PubMed ID: 35775861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective analysis of molecular testing in cytologically indeterminate thyroid nodules with histologic correlation: Experience at a heterogenous multihospital system.
    Sura GH; Thrall MJ; Rogers J; Hodjat P; Christensen P; Cubb TD; Khadra HS; Thomas JS; Jacobi EM
    Diagn Cytopathol; 2024 Feb; 52(2):82-92. PubMed ID: 37950548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of atypia/follicular lesion of undetermined significance on the rate of malignancy in thyroid fine-needle aspiration: evaluation of the Bethesda System for Reporting Thyroid Cytopathology.
    Broome JT; Solorzano CC
    Surgery; 2011 Dec; 150(6):1234-41. PubMed ID: 22136846
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced HBME-1 immunoreactivity of papillary thyroid carcinoma and papillary thyroid carcinoma-related neoplastic lesions with Hürthle cell and/or apocrine-like changes.
    Mai KT; Bokhary R; Yazdi HM; Thomas J; Commons AS
    Histopathology; 2002 Feb; 40(2):133-42. PubMed ID: 11952857
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The meaning and predictivity of Hürthle cells in fine needle aspiration cytology for thyroid nodular disease.
    Kauffmann PR; Dejax C; de Latour M; Dauplat J
    Eur J Surg Oncol; 2004 Sep; 30(7):786-9. PubMed ID: 15296995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytological features of "noninvasive follicular thyroid neoplasm with papillary-like nuclear features" and their correlation with tumor histology.
    Maletta F; Massa F; Torregrossa L; Duregon E; Casadei GP; Basolo F; Tallini G; Volante M; Nikiforov YE; Papotti M
    Hum Pathol; 2016 Aug; 54():134-42. PubMed ID: 27085556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fine needle aspiration of the thyroid: correlation with final histopathology in a surgical series of 797 patients.
    Lew JI; Snyder RA; Sanchez YM; Solorzano CC
    J Am Coll Surg; 2011 Jul; 213(1):188-94; discussion 194-5. PubMed ID: 21601489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.